SQSTM1 and hepatocellular carcinoma: Further study showed that inhibition of phosphorylated p62-dependent Nrf2 activation by N-[2-acetonyl-4-(4-ethoxybenzenesulfonylamino) naphthalene-1-yl]-4-ethoxybenzenesulfonamide (named as K67) suppresses the proliferation and drug resistance of HCC.